Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine

Phase 2

Terminated

Conditions: Renal Cell Carcinoma

Interventions: Drug: CT-011
Biological: DC/RCC fusion vaccine

First Posted Date: 2011-09-28

Last Posted Date: 2017-02-08

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 11

Registration Number: NCT01441765

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Aerosol Inhalation Treatment for Dyspnea

Phase 1

Completed

Conditions: Healthy
Dyspnea

Interventions: Drug: Furosemide
Drug: Saline

First Posted Date: 2011-09-27

Last Posted Date: 2017-06-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 24

Registration Number: NCT01440764

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Kidney Donor Outcomes Cohort (KDOC) Study

Completed

Conditions: Living Donor Nephrectomy

First Posted Date: 2011-09-01

Last Posted Date: 2018-03-20

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 720

Registration Number: NCT01427452

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
Maine Medical Center, Portland, Maine, United States

and more 4 locations

Effects of Pre-, Pro- & Anti-biotics on Gut Microbiota

Not Applicable

Completed

Conditions: Human Gut Microbiota

Interventions: Dietary Supplement: Trametes versicolor extract
Dietary Supplement: Saccharomyces boulardii
Drug: Amoxicillin

First Posted Date: 2011-08-11

Last Posted Date: 2017-07-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 32

Registration Number: NCT01414010

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)

Phase 1

Terminated

Conditions: Chronic Myelogenous Leukemia

Interventions: Drug: Arsenic trioxide

First Posted Date: 2011-07-20

Last Posted Date: 2018-09-06

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 7

Registration Number: NCT01397734

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

Phase 2

Completed

Conditions: Schizophrenic Psychoses

Interventions: Drug: Placebo
Drug: n-acetylcysteine

First Posted Date: 2011-05-16

Last Posted Date: 2017-07-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT01354132

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts Mental Health Center, Boston, Massachusetts, United States

Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease

Completed

Conditions: Ulcerative Colitis
Crohn's Disease

First Posted Date: 2011-05-06

Last Posted Date: 2013-08-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 106

Registration Number: NCT01349504

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Effectiveness of Open and Robotic Prostatectomy

Completed

Conditions: Prostate Cancer

Interventions: Other: Questionnaire

First Posted Date: 2011-03-29

Last Posted Date: 2024-11-06

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 677

Registration Number: NCT01325506

Locations: 🇺🇸
Emory Healthcare, Atlanta, Georgia, United States
🇺🇸
Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

and more 6 locations

Coenzyme Q10 in Post-Cardiac Arrest Cerebral Resuscitation

Phase 2

Completed

Conditions: Sudden Cardiac Arrest
Cardiac Arrest

Interventions: Dietary Supplement: Placebo
Drug: Coenzyme Q10

First Posted Date: 2011-03-21

Last Posted Date: 2017-07-31

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 10

Registration Number: NCT01319110

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The VMVN Study: Virological Monitoring in Viet Nam

Not Applicable

Completed

Conditions: HIV Infection
AIDS

Interventions: Other: Virological Monitoring
Other: Standard Care

First Posted Date: 2011-03-17

Last Posted Date: 2018-08-03

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 650

Registration Number: NCT01317498

Locations: 🇻🇳
Bach Mai Hospital, Hanoi, Vietnam

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy